NS

Nandadip Sakharam Rasam

Active Director Director DIN 10150322
DIN 10150322 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandadip Sakharam Rasam

Data last updated:

Nandadip Sakharam Rasam is a Director at Sequel Pharmaceuticals (India) Private Limited (since 2023). The company operates in Pharma.

DIN 10150322
Primary Designation Director
Industry Pharma
First Appointment 06 May 2023
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 May 20232006Active

Board colleagues of Nandadip Sakharam Rasam

Directorship timeline

Open interactive timeline →
Sequel Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Nandadip Sakharam Rasam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandadip Sakharam Rasam

Nandadip Sakharam Rasam currently holds 1 directorship: Sequel Pharmaceuticals (India) Private Limited (Director, since 06 May 2023).

Nandadip Sakharam Rasam was first appointed on 06 May 2023 as Director at Sequel Pharmaceuticals (India) Private Limited.

The current boards of Nandadip Sakharam Rasam's companies include Ramchandra Haridas Parade (Sequel Pharmaceuticals (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available